Výsledky vyhledávání - "Kyoko Katsumata"

Monthly oral ibandronate 100 mg is as effective as monthly intravenous ibandronate 1 mg in patients with various pathologies in the MOVEST study

Autor: Yoshihiro Asao, Kyoko Katsumata, Junko Hashimoto, Rumiko Matsumoto, Hideki Mizunuma, Koichi Endo, Masao Yamamoto, Toshitaka Nakamura, Tetsuo Nakano, Hiroshi Hagino, Masako Ito

Publikováno v: Journal of Bone and Mineral Metabolism. 36:336-343

The non-inferiority of oral ibandronate 100 mg to intravenous (i.v.) ibandronate 1 mg in increasing lumbar spine (LS) bone mineral density (BMD) after 12 months of treatment was demonstrated in the randomized, phase III MOVEST study. We conducted sub

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0076e218a7b42d48950d8c3caa132f06
https://doi.org/10.1007/s00774-017-0839-2

Zobrazit plný text záznamu

Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats

Autor: Naoshi Fukushima, Kyoko Katsumata, Steven K. Burke, Nobuo Nagano, Kunihiko Tsunemi, Kenichiro Kusano, Michinori Hirata

Publikováno v: Kidney International. 64(2):441-450

Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Background Hyperphosphatemia is associated with severe complications, including ectopic calcification of soft tissues, secondary hyperparat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1ea0ed326a202118623eb67b599ed8

Zobrazit plný text záznamu

1,25-Dihydroxyvitamin D3 as Well as Its Analogue OCT Lower Blood Calcium Through Inhibition of Bone Resorption in Hypercalcemic Rats with Continuous Parathyroid Hormone-Related Peptide Infusion

Autor: Toshitaka Nakamura, Etsuro Ogata, Toshimi Masaki, Koichi Endo, Kyoji Ikeda, Kyoko Katsumata, Noboru Kubodera, Michinori Hirata

Publikováno v: Journal of Bone and Mineral Research. 15:175-181

The effects of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and its analogue 22-oxa-1,25(OH)2D3 (22-oxacalcitriol) (OCT) on calcium and bone metabolism were examined in an animal model of hypercalcemia with continuous infusion of parathyroid hormone-relate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a10425c1377e99c3334dbc5fbff0e6
https://doi.org/10.1359/jbmr.2000.15.1.175

Zobrazit plný text záznamu

Attenuated up-regulation of vitamin D-dependent calcium-binding proteins by 22-oxa-1,25-dihydroxyvitamin D3in uremic rats: A possible mechanism for less-calcemic action

Autor: Hiroyuki Ohkawa, Noboru Kubodera, Fumihiko Ichikawa, Masafumi Fukagawa, Koichi Endo, Michinori Hirata, Kiyoshi Kurokawa, Kyoko Katsumata

Publikováno v: Nephrology. 4:391-395

SUMMARY: 22-Oxa-1,25-dihydroxyvitamin D3 (OCT) is an analogue of vitamin D with less calcemic action than 1,25-dihydroxyvitamin D3 (1,25D3), and thus may be advantageous in the treatment of secondary hyperparathyroidism in dialysis patients. to furth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b908e0dd7ee5883b2867a06604e64ca1
https://doi.org/10.1111/j.1440-1797.1998.tb00377.x

Zobrazit plný text záznamu

Effect of Combination Treatment with a Vitamin D Analog (OCT) and a Bisphosphonate (AHPrBP) in a Nude Mouse Model of Cancer-Associated Hypercalcemia

Autor: Kyoji Ikeda, Haruo Iguchi, Etsuro Ogata, Noboru Kubodera, Kyoko Katsumata, Toshiro Fujita, Tamio Teramoto, Koichi Endo

Publikováno v: Journal of Bone and Mineral Research. 13:1378-1383

Hypercalcemia represents one of the important paraneoplastic syndromes affecting morbidity and mortality of cancer patients. We and others have demonstrated that vitamin D analogs with little calcemic activities suppress the transcription of the para

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a6650c2e5513011c7c532ccf9b916d5
https://doi.org/10.1359/jbmr.1998.13.9.1378

Zobrazit plný text záznamu

Evidence for the uptake of a vitamin D analogue (OCT) by a human carcinoma and its effect of suppressing the transcription of parathyroid hormone-related peptide gene in vivo

Autor: Kenji Kumaki, Koichi Endo, Etsuro Ogata, Kyoko Katsumata, Hiroyuki Ohkawa, Yasushi Uchiyama, Fumihiko Ichikawa, Kyoji Ikeda

Publikováno v: Journal of Biological Chemistry. 269:32693-32699

The present study was undertaken to clarify the pharmacokinetics of 22-oxa-1,25-dihydroxyvitamin D3 (22-oxa-1,25-(OH)2D3, OCT), a vitamin D3 analogue with little calcemic activity, and its effect on the transcription of parathyroid hormone-related pe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cc5bfd4be9f251eb250eafa04a7d1a8
https://doi.org/10.1016/s0021-9258(18)31690-9

Zobrazit plný text záznamu

Akademický článek

Lignin characteristics of peculiar vascular plants.

Autor: Zhenfu Jin, Shunliu Shao, Kyoko Katsumata, Kenji Iiyama

Publikováno v: Journal of Wood Science; Dec2007, Vol. 53 Issue 6, p520-523, 4p

Zobrazit plný text záznamu

Akademický článek

Structural changes in lignin of tropical woods during digestion by termite, Cryptotermes brevis.

Autor: Kyoko Katsumata, Zhenfu Jin, Keko Hori, Kenji Iiyama

Publikováno v: Journal of Wood Science; Oct2007, Vol. 53 Issue 5, p419-426, 8p

Zobrazit plný text záznamu

Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis

Autor: Junko Hashimoto, Kyoko Katsumata, H. Hagino, Masako Ito, K. Shinomiya, Toshitaka Nakamura, T. Inoue, Y. Asao, T. Nakano, Hideki Mizunuma

Publikováno v: Osteoporosis International

Summary: The MOVEST study evaluated the efficacy and safety of monthly oral ibandronate versus licensed monthly IV ibandronate in Japanese osteoporotic patients. Relative BMD gains after 12 months were 5.22 % oral and 5.34 % IV, showing non-inferiori

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::802ebf2ff4903f7b6d612e3a31771159

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání